(en) D. G. Bailey, G. Dresser et J. M. O. Arnold, « Grapefruit-medication interactions: Forbidden fruit or avoidable consequences? », Canadian Medical Association Journal, vol. 185, no 4, , p. 309–316 (ISSN0820-3946 et 1488-2329, PMID23184849, PMCIDPMC3589309, DOI10.1503/cmaj.120951)
(en) D.G. Bailey, J.D. Spence, C. Munoz et J.M.O. Arnold, « Interaction of citrus juices with felodipine and nifedipine », The Lancet, vol. 337, no 8736, , p. 268–269 (ISSN0140-6736, DOI10.1016/0140-6736(91)90872-m)
(en) D Greenblatt, « Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice », Clinical Pharmacology & Therapeutics, vol. 74, no 2, , p. 121–129 (DOI10.1016/S0009-9236(03)00118-8)
(en) D Bailey, « Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3a4 activity: comparison with grapefruit juice, », Clinical Pharmacology & Therapeutics, vol. 73, no 6, , p. 529–537 (DOI10.1016/S0009-9236(03)00051-1)
(en) Meng Chen, Shu-yi Zhou, Erlinda Fabriaga et Pian-hong Zhang, « Food-drug interactions precipitated by fruit juices other than grapefruit juice: An update review », Journal of Food and Drug Analysis, vol. 26, no 2, , S61–S71 (DOI10.1016/j.jfda.2018.01.009)
(en) David J. Edwards et Suzanne M. Bernier, « Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice », Life Sciences, vol. 59, no 13, , p. 1025–1030 (DOI10.1016/0024-3205(96)00417-1)
(en) Mary F. Paine, Wilbur W. Widmer, Heather L. Hart et Susan N. Pusek, « A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice–felodipine interaction », The American Journal of Clinical Nutrition, vol. 83, no 5, , p. 1097–1105 (ISSN0002-9165, DOI10.1093/ajcn/83.5.1097)
(en) Wichittra Tassaneeyakul, Lian-Qing Guo, Katsuyuki Fukuda et Tomihisa Ohta, « Inhibition Selectivity of Grapefruit Juice Components on Human Cytochromes P450 », Archives of Biochemistry and Biophysics, vol. 378, no 2, , p. 356–363 (ISSN0003-9861, DOI10.1006/abbi.2000.1835)
Kan He, Krishna R. Iyer, Roger N. Hayes et Michael W. Sinz, « Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice », Chemical Research in Toxicology, vol. 11, no 4, , p. 252–259 (ISSN0893-228X, DOI10.1021/tx970192k)
(en) Santosh K. Garg, Naresh Kumar, Vinod K. Bhargava et Sudesh K. Prabhakar, « Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy », Clinical Pharmacology & Therapeutics, vol. 64, no 3, , p. 286–288 (ISSN1532-6535, DOI10.1016/S0009-9236(98)90177-1)
(en) Dr David G. Bailey et George K. Dresser, « Interactions Between Grapefruit Juice and Cardiovascular Drugs », American Journal of Cardiovascular Drugs, vol. 4, no 5, , p. 281–297 (ISSN1179-187X, DOI10.2165/00129784-200404050-00002)
(en) Maria L. Veronese, Lisa P. Gillen, Joanne P. Burke et Ellen P. Dorval, « Exposure-Dependent Inhibition of Intestinal and Hepatic CYP3A4 In Vivo by Grapefruit Juice », The Journal of Clinical Pharmacology, vol. 43, no 8, , p. 831–839 (ISSN1552-4604, DOI10.1177/0091270003256059)
(en) Mitsuo Saito, Mutsuko Hirata-Koizumi, Mariko Matsumoto et Tsutomu Urano, « Undesirable Effects of Citrus Juice on the Pharmacokinetics of Drugs: Focus on Recent Studies », Drug Safety, vol. 28, no 8, , p. 677–694 (ISSN0114-5916, DOI10.2165/00002018-200528080-00003)
(en) Chunxian Chen, Qibin Yu, Xu Wei et Paul F. Cancalon, « Identification of genes associated with low furanocoumarin content in grapefruit », Genome, vol. 57, no 10, , p. 537–545 (ISSN0831-2796, DOI10.1139/gen-2014-0164)
(en) J. Lundahl, C. G. Regårdh, B. Edgar et G. Johnsson, « Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects », European Journal of Clinical Pharmacology, vol. 49, no 1, , p. 61–67 (ISSN1432-1041, DOI10.1007/BF00192360)
(en-US) David J. Greenblatt, Kiran C. Patki, Lisa L. von Moltke et Richard I. Shader, « Drug Interactions With Grapefruit Juice: An Update », Journal of Clinical Psychopharmacology, vol. 21, no 4, , p. 357–359 (ISSN0271-0749, DOI10.1097/00004714-200108000-00001)
(en) Wilbur Widmer, « One Tangerine/Grapefruit Hybrid (Tangelo) Contains Trace Amounts of Furanocoumarins at a Level Too Low To Be Associated with Grapefruit/Drug Interactions », Journal of Food Science, vol. 70, no 6, , c419–c422 (ISSN1750-3841, DOI10.1111/j.1365-2621.2005.tb11440.x)
Jérôme Sicard, Fabrice Veron et Leila Chaouachi, « Congrès européen de cancérologie, actualité des traitements », Actualités Pharmaceutiques, vol. 59, no 594, , p. 41–44 (DOI10.1016/j.actpha.2020.01.012, lire en ligne, consulté le )
(en) Chittaranjan Andrade, « Potentially Significant Versus Clinically Significant Drug Interactions: Pomegranate Juice as a Case in Point », The Journal of Clinical Psychiatry, vol. 75, no 4, , p. 292–293 (ISSN0160-6689, DOI10.4088/JCP.14f09112)
elsevier.com
linkinghub.elsevier.com
Jérôme Sicard, Fabrice Veron et Leila Chaouachi, « Congrès européen de cancérologie, actualité des traitements », Actualités Pharmaceutiques, vol. 59, no 594, , p. 41–44 (DOI10.1016/j.actpha.2020.01.012, lire en ligne, consulté le )
(en) D. G. Bailey, G. Dresser et J. M. O. Arnold, « Grapefruit-medication interactions: Forbidden fruit or avoidable consequences? », Canadian Medical Association Journal, vol. 185, no 4, , p. 309–316 (ISSN0820-3946 et 1488-2329, PMID23184849, PMCIDPMC3589309, DOI10.1503/cmaj.120951)
(en) D.G. Bailey, J.D. Spence, C. Munoz et J.M.O. Arnold, « Interaction of citrus juices with felodipine and nifedipine », The Lancet, vol. 337, no 8736, , p. 268–269 (ISSN0140-6736, DOI10.1016/0140-6736(91)90872-m)
(en) Mary F. Paine, Wilbur W. Widmer, Heather L. Hart et Susan N. Pusek, « A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice–felodipine interaction », The American Journal of Clinical Nutrition, vol. 83, no 5, , p. 1097–1105 (ISSN0002-9165, DOI10.1093/ajcn/83.5.1097)
(en) Wichittra Tassaneeyakul, Lian-Qing Guo, Katsuyuki Fukuda et Tomihisa Ohta, « Inhibition Selectivity of Grapefruit Juice Components on Human Cytochromes P450 », Archives of Biochemistry and Biophysics, vol. 378, no 2, , p. 356–363 (ISSN0003-9861, DOI10.1006/abbi.2000.1835)
(en-US) Nicholas Bakalar, « Experts Reveal the Secret Powers of Grapefruit Juice », The New York Times, (ISSN0362-4331, lire en ligne, consulté le )
Kan He, Krishna R. Iyer, Roger N. Hayes et Michael W. Sinz, « Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice », Chemical Research in Toxicology, vol. 11, no 4, , p. 252–259 (ISSN0893-228X, DOI10.1021/tx970192k)
(en) Santosh K. Garg, Naresh Kumar, Vinod K. Bhargava et Sudesh K. Prabhakar, « Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy », Clinical Pharmacology & Therapeutics, vol. 64, no 3, , p. 286–288 (ISSN1532-6535, DOI10.1016/S0009-9236(98)90177-1)
(en) Dr David G. Bailey et George K. Dresser, « Interactions Between Grapefruit Juice and Cardiovascular Drugs », American Journal of Cardiovascular Drugs, vol. 4, no 5, , p. 281–297 (ISSN1179-187X, DOI10.2165/00129784-200404050-00002)
Rubin Bressler, « Grapefruit juice and drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs », Geriatrics, vol. 61, no 11, , p. 12–18 (ISSN1936-5764, PMID17112309)
(en) Maria L. Veronese, Lisa P. Gillen, Joanne P. Burke et Ellen P. Dorval, « Exposure-Dependent Inhibition of Intestinal and Hepatic CYP3A4 In Vivo by Grapefruit Juice », The Journal of Clinical Pharmacology, vol. 43, no 8, , p. 831–839 (ISSN1552-4604, DOI10.1177/0091270003256059)
(en) Mitsuo Saito, Mutsuko Hirata-Koizumi, Mariko Matsumoto et Tsutomu Urano, « Undesirable Effects of Citrus Juice on the Pharmacokinetics of Drugs: Focus on Recent Studies », Drug Safety, vol. 28, no 8, , p. 677–694 (ISSN0114-5916, DOI10.2165/00002018-200528080-00003)
(en) Chunxian Chen, Qibin Yu, Xu Wei et Paul F. Cancalon, « Identification of genes associated with low furanocoumarin content in grapefruit », Genome, vol. 57, no 10, , p. 537–545 (ISSN0831-2796, DOI10.1139/gen-2014-0164)
(en) J. Lundahl, C. G. Regårdh, B. Edgar et G. Johnsson, « Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects », European Journal of Clinical Pharmacology, vol. 49, no 1, , p. 61–67 (ISSN1432-1041, DOI10.1007/BF00192360)
(en-US) David J. Greenblatt, Kiran C. Patki, Lisa L. von Moltke et Richard I. Shader, « Drug Interactions With Grapefruit Juice: An Update », Journal of Clinical Psychopharmacology, vol. 21, no 4, , p. 357–359 (ISSN0271-0749, DOI10.1097/00004714-200108000-00001)
(en) Wilbur Widmer, « One Tangerine/Grapefruit Hybrid (Tangelo) Contains Trace Amounts of Furanocoumarins at a Level Too Low To Be Associated with Grapefruit/Drug Interactions », Journal of Food Science, vol. 70, no 6, , c419–c422 (ISSN1750-3841, DOI10.1111/j.1365-2621.2005.tb11440.x)
(en) Chittaranjan Andrade, « Potentially Significant Versus Clinically Significant Drug Interactions: Pomegranate Juice as a Case in Point », The Journal of Clinical Psychiatry, vol. 75, no 4, , p. 292–293 (ISSN0160-6689, DOI10.4088/JCP.14f09112)
J. Seidegård, G. Randvall, L. Nyberg et O. Borgå, « Grapefruit juice interaction with oral budesonide: equal effect on immediate-release and delayed-release formulations », Die Pharmazie, vol. 64, no 7, , p. 461–465 (ISSN0031-7144, PMID19694184, lire en ligne, consulté le )
(en) D. G. Bailey, G. Dresser et J. M. O. Arnold, « Grapefruit-medication interactions: Forbidden fruit or avoidable consequences? », Canadian Medical Association Journal, vol. 185, no 4, , p. 309–316 (ISSN0820-3946 et 1488-2329, PMID23184849, PMCIDPMC3589309, DOI10.1503/cmaj.120951)
Rubin Bressler, « Grapefruit juice and drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs », Geriatrics, vol. 61, no 11, , p. 12–18 (ISSN1936-5764, PMID17112309)
J. Seidegård, G. Randvall, L. Nyberg et O. Borgå, « Grapefruit juice interaction with oral budesonide: equal effect on immediate-release and delayed-release formulations », Die Pharmazie, vol. 64, no 7, , p. 461–465 (ISSN0031-7144, PMID19694184, lire en ligne, consulté le )
nytimes.com
nytimes.com
(en-US) Nicholas Bakalar, « Experts Reveal the Secret Powers of Grapefruit Juice », The New York Times, (ISSN0362-4331, lire en ligne, consulté le )
(en) Maria Calvarano, Enrico Postorino, Francesco Gionfriddo, Ignazio Calvarano and Francesco Bovalo, Giuseppe Calabro, « Naringin Extraction from Exhausted Bergamot Peels », sur Perfumer & Flavorist (consulté le )